The real danger of medical referrals: Physician overconfidence and lack of quality assessment

Article Highlights

  • Remember how great things used to be, when doctors were highly regarded and patients were meek and grateful in their presence?

    Tweet This

  • It's still surprising how frequently we reference, and pine for, the supposedly good old days of medicine

    Tweet This

Of the many factors that make improving the health system difficult, few challenges are greater than the misty-eyed recollection - often from genuinely distinguished practitioners - of how great things used to be.  Doctors were highly regarded authority figures, pure and beloved, while patients were meek and grateful in the presence of such brilliance and expertise.

Of course, this caricature has been thoroughly debunked - perhaps to an excessive degree (I've actually argued that many of those jumping on the desperately hip "disrupt medicine" bandwagon may be missing or at least undervaluing important elements of the "traditional" doctor-patient relationship).

Nevertheless, it's still surprising how frequently we reference, and pine for, the supposedly good old days of medicine, a misinformed comparison that tends only to muddy the waters and prevent us from focusing in on the real problems to be solved.

A representative case in point is an article today from Smart Money describing the emerging business of specialist referrals.  The basic idea is that if you see your primary care doctor, and need expert evaluation in a particular area (such as surgery or endocrinology), you get referred to an appropriate specialist.  The article makes the point that while patients believe these referrals are on basis of their doctor's opinion of the expert's quality, in fact they may be based on the aggressive marketing of a dedicated consultant who the expert hired to increase business.

Unfortunately, rather than arguing both of these approaches are misguided, the author fondly invokes "a now-retired Nobel Prize winning cardiologist who practiced for more than five decades in the Boston area who says the emphasis [in the old days] was usually on someone's medical bona fides - where they trained, what they published and what they've accomplished as a healer. The bottom line, he says: ‘They looked for patient outcomes.'"

Say what?  If there's one thing abundantly clear about the practice of medicine (and look no further than this op-ed in today's NYT, and this recent HBR contribution by same authors), it's the nearly total lack of visibility into actual outcomes, and beyond that, to physician quality.  

It's true: we may have a sense of how knowledgeable other doctors may seem in conversation, we know where they trained and who they trained with, and we can figure out pretty quickly if their patients tend to like them or not; but do we know the quality of the care they ultimately are providing?  Generally, the answer is no - and to believe otherwise suggests profound physician overconfidence, of exactly the sort described by Kahneman in so many other domains.

The key take-away from the medical referral story shouldn't be: let's go back to the old days when doctors cared enough to refer patients to the best specialists  - or at least the specialists they knew best. 

Instead, let's use this opportunity to think a bit more carefully about how to measure the quality of care (non-trivial), and particularly the ability of doctors to achieve improved patient outcomes.  Such an approach could not only help primary care physicians give the best advice to their patients, but could also help the specialists themselves improve the care they provide, and elevate the overall quality of our medical system.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

David
Shaywitz
  • Dr. Shaywitz trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco.

  • Email: davidshaywitz.aei@gmail.com

What's new on AEI

image How to stop Assad's slaughter
image FHA Watch, May 2013 (Vol. 2, No. 5)
image Apple becomes latest target of the Beltway shakedown
image Lack of adult supervision in the Obama administration
AEI on Facebook
Events Calendar
  • 20
    MON
  • 21
    TUE
  • 22
    WED
  • 23
    THU
  • 24
    FRI
Tuesday, May 21, 2013 | 5:00 p.m. – 6:30 p.m.
Free beer: Liberating libations from ‘Bootleggers and Baptists’

Join us for a discussion of the history and future of federal and state alcohol regulation and competition, followed by a reception with beer, wine, and spirits.

Wednesday, May 22, 2013 | 5:00 p.m. – 6:30 p.m.
NCLB sanctions: Tests taken, lessons learned

Join education scholars and practitioners for a discussion about the latest NCLB research and its implications for future education policy.

Thursday, May 23, 2013 | 12:00 p.m. – 1:30 p.m.
Competing visions of the common good: Rethinking help for the poor

What shared commitments do we have as citizens and neighbors to care for one another? How can a proper ordering of America’s political economy enable the most people to have the best life? At this event, Rep. Frank Wolf (R-VA), a longtime champion of human rights causes, and AEI President Arthur Brooks will join Wallis in addressing these and other questions.

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.